FIGURE 3.
Relation predictive values (including monthly migraine days [MMD] reduction) and the reduction in depressive symptoms. Reduction in HADS‐D is positively associated with MMD reduction, but treatment with anti‐CGRP medication had an additional effect on the reduction in HADS‐D (β = 1.65, p = 0.01) compared to control.